EUVIMEDEUVIMED entdecken
Open Access

Enantioselective analysis of metoprolol in plasma of hypertensive patients undergoing long-term therapy: Insights for personalized medicine

Behrouz Seyfinejad iD, Kimiya Jouyban iD, Jalil Houshyar, Amirreza Jabbaripour Sarmadian, Abolghasem Jouyban iD

BioImpacts · 30.11.2025 · 15 · 32645

DOI: 10.34172/bi.32645 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioImpacts, online erschienen am 30.11.2025. Verfasst von Behrouz Seyfinejad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cellular and Molecular Research Center, Cellular and Molecular Medicine Research Institute, Urmia University of Medical Sciences, Urmia, Iran. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Metoprolol is therapeutically formulated as a racemate with stereoselective pharmacokinetics influenced by CYP2D6 polymorphism. Understanding enantioselective disposition is critical for optimizing therapy in hypertensive patients, particularly during long-term treatment, where metabolic and excretory pathways may interact unpredictably.

Methods

This study analyzed plasma samples from 18 hypertensive patients on long-term metoprolol therapy using a validated chiral capillary electrophoresis method. Enantiomer concentrations were quantified, and S/R ratios were evaluated alongside patient demographics, dosing regimens, and co-administered drugs. The study design focused on identifying deviations from expected enantiomeric patterns observed in single-dose or short-term multi-dose administration in healthy individuals studies.

Results

While most patients (70%) exhibited the anticipated S/R ratio≥1, 30% demonstrated inverted plasma S/R ratios (

Schlagwörter

Stichwörter der Autor:innen

CYP2D6EnantiomersEnantioselective excretionHypertensionMetoprololPersonalized medicine

Autor:innen und Institutionen

  • Cellular and Molecular Research Center, Cellular and Molecular Medicine Research Institute, Urmia University of Medical Sciences, Urmia, Iran.
  • Pharmaceutical Analysis Research Center, Pharmaceutical Sciences Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Endocrine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.

ORCID-Profile: Behrouz Seyfinejad, Kimiya Jouyban, Abolghasem Jouyban

Zitieren

APA

Seyfinejad, B., Jouyban, K., Houshyar, J., Jabbaripour Sarmadian, A., & Jouyban, A. (2025). Enantioselective analysis of metoprolol in plasma of hypertensive patients undergoing long-term therapy: Insights for personalized medicine. BioImpacts, 15, 32645. https://doi.org/10.34172/bi.32645

Vancouver

Seyfinejad B, Jouyban K, Houshyar J, Jabbaripour Sarmadian A, Jouyban A. Enantioselective analysis of metoprolol in plasma of hypertensive patients undergoing long-term therapy: Insights for personalized medicine. BioImpacts. 2025;15:32645. doi:10.34172/bi.32645

BibTeX
@article{Seyfinejad2025,
  author = {Seyfinejad, Behrouz and Jouyban, Kimiya and Houshyar, Jalil and Jabbaripour Sarmadian, Amirreza and Jouyban, Abolghasem},
  title = {Enantioselective analysis of metoprolol in plasma of hypertensive patients undergoing long-term therapy: Insights for personalized medicine},
  journal = {BioImpacts},
  year = {2025},
  volume = {15},
  pages = {32645},
  doi = {10.34172/bi.32645}
}
Kostenlos starten →